Introduction {#sec1_1}
============

Femtosecond laser-assisted in situ keratomileusis (femto-LASIK) is considered a safe surgical procedure to correct low and medium myopia, hyperopia, and astigmatism. Diffuse lamellar keratitis (DLK) is a relatively infrequent complication of LASIK \[[@B1]\]. It may occur after any surgical procedure in which a corneal lamellar incision has created an interface through the stromal tissue.

DLK is a self-perpetuating sterile inflammation of the cornea characterized by the appearance of a diffuse, multifocal, polymorphonuclear infiltration in the flap interface \[[@B1], [@B2]\]. Its origins are unclear; early signs are usually evident since the first postoperative day, but in some cases by day 3--4, such as cloud-like white areas evident in the interface due to the stromal melting caused by the release of proteolytic enzymes from polymorphonuclear cells. Consequently, a reduction in visual acuity occurs.

Robert Maddox was the first surgeon who reported on this mysterious post-LASIK inflammatory syndrome in 1996 \[[@B3]\]. The differential diagnosis includes infective keratitis and inclusions in the interface.

We report a case of severe DLK following femto-LASIK successfully treated without corneal flap lifting with 1 year of follow-up. To our knowledge, there are only few case reports or series of grade 4 DLK after femto-LASIK \[[@B4], [@B5]\], and no descriptions but one \[[@B6]\] of the clinical evolution of this syndrome with anterior segment optical coherence tomography (OCT) has been published. We suggest anterior segment OCT as a very effective method to follow the course and the severity of corneal stromal involvement.

Materials and Methods {#sec1_2}
=====================

In February 2017, a 25-year-old man was referred to us for correction of his myopic astigmatism. Best corrected visual acuity was 20/20 in both eyes (cycloplegic refraction: −1.50 = −0.50 at 180° in the right eye and −1.75 = −0.25 at 180° in the left eye). Slit lamp biomicroscopy revealed normal features. Intraocular pressure by applanation tonometry was 17 mm Hg in both eyes. Topographic simulated keratometry (Sim K) readings at 3 mm were 42.23 D at 1°, 43.04 D at 91° in the right eye and 42.70 at 1°, 43.57 D at 91° in the left eye (CSO Corneal Topography MODI\'02, Florence, Italy) (Fig. [1a](#F1){ref-type="fig"}). Central corneal thickness was 600 μm in the right eye and 610 μm in the left eye at OCT of the anterior segment (Optovue RTVue-100, USA).

Femto-LASIK was performed the same day in both eyes with 150 kHz iFS® Femtosecond Laser (Abbott Medical Optics, AMO Manufacturing, USA). The corneal flap was 110 μm thick and 8.8 mm large. Laser treatment was completed using the Bausch & Lomb 217z100 Excimer Laser Platform (Rochester, NY, USA). The day after surgery, uncorrected visual acuity (UCVA) was 20/25 in the right eye and 20/20 in the left eye, but the patient complained of blurred vision in his left eye since a few hours after the procedure. At slit lamp examination a slightly diffuse whitish granular cell reaction was detected, more evident in the right eye. A diagnosis of early DLK was made (Fig. [2a, b](#F2){ref-type="fig"}).

The patient was examined day by day. We prescribed topical dexamethasone eyedrops hourly for the first day and every 2 h from day 2, tobramycin eyedrops 3 times a day for the first week, and artificial tears. On day 5, slit lamp biomicroscopy showed a corneal opacity in both eyes, like a scar, more dense in the center, with corneal striae moving towards the infiltrate (Fig. [2c, d](#F2){ref-type="fig"}). UCVA had decreased to 20/32 in both eyes. OCT of the anterior segment showed a large hyperreflective area about 3 mm wide and 330 μm deep (Fig. [3a, b](#F3){ref-type="fig"}). Sim K readings at 3 mm were 39.24 D at 97°, 38.63 D at 56° in the right eye and 37.86 D at 75°, 34.05 D at 10° in the left eye. Minimal corneal thickness was 413 μm in the right eye and 438 μm in the left eye. A diagnosis of severe DLK (grade 4) was made.

We started treatment with oral doxycycline twice a day for 2 weeks, then once a day for 1 month, and topical 10% sodium citrate 3 times a day. Dexamethasone eyedrops were prescribed 5 times a day for 1 month, 3 times a day for another month, and twice a day during the third month, with artificial tears.

Two days later, the infiltrate and the whitish granular cell reaction were slightly reduced. UCVA was 20/50 in both eyes. Two weeks after surgery, UCVA was 20/32, and central corneal thickness was 435 μm in the right eye and 489 μm in the left eye. We tapered topical therapy over 4 months and started treatment with topical hyperosmolar ophthalmological solution (sodium chloride 5%, sodium hyaluronate 0.15%) 3 times a day for 3 months.

One month after surgery, UCVA was 20/80 in both eyes, 20/20 with pinhole occluder; autorefractometry readings were +3.50 = −4.25 at 130° in the right eye and +4.50 = −5.75 at 25° in the left eye; the cornea was clearer (Fig. [2e, f](#F2){ref-type="fig"}). At the anterior segment, OCT stromal hyperreflectivity was less wide and deep (Fig. [3c, d](#F3){ref-type="fig"}). Corneal topography showed irregular astigmatism (Fig. [1b](#F1){ref-type="fig"}).

At 3 months, thin microstriae affected the flap in both eyes (Fig. [2g, h](#F2){ref-type="fig"}), and UCVA was \> 20/25 in both eyes. Sim K readings at 3 mm were 38.43 D at 156°, 39.52 D at 66° in the right eye and 39.52 D at 1°, 40.43 D at 91° in the left eye; the corneal topographic pattern was more regular and the corneal flattening area smaller (Fig. [1c](#F1){ref-type="fig"}). Anterior-segment OCT showed only few signs of hyperreflectivity (Fig. [3e, f](#F3){ref-type="fig"}).

At 6 months, UCVA was 20/25 in both eyes, OCT was almost normal (Fig. [3g, h](#F3){ref-type="fig"}), and Sim K readings at 3 mm were 39.69 D at 145°, 40.37 D at 55° in the right eye and 39.79 D at 11°, 41.02 D at 101° in the left eye (Fig. [1d](#F1){ref-type="fig"}). Central corneal thickness was 500 μm in the right eye and 450 μm in the left eye; the latter showed very thin vertical microstriae.

At 1 year, UCVA was 20/20 in both eyes, and OCT confirmed completely DLK regression (Fig. [3i, j](#F3){ref-type="fig"}). Topographic Sim K readings at 3 mm were 39.23 D at 167°, 39.99 D at 77° in the right eye and 39.71 D at 7°, 40.78 D at 97° in the left eye (Fig. [1e](#F1){ref-type="fig"}). Central corneal thickness was unchanged. Thin microstriae were still visible in the left eye (Fig. [2i, j](#F2){ref-type="fig"}).

Discussion {#sec1_3}
==========

In 1998, Smith and Maloney \[[@B2]\] described an unusual noninfective inflammatory reaction of the interface early after LASIK in 13 cases of keratitis with whitish granular elements; the condition was called DLK. Several communications were presented on this topic in 1998, and the condition was named "sands of the Sahara" syndrome, alluding to the sand-like granular aspect of the infiltrate in the interface, nonspecific diffuse intralamellar keratitis and diffuse intralamellar keratitis \[[@B7]\].

The incidence of DLK reported in the literature varies between 0.2 and 1.8% \[[@B8]\]. It occurs after primary LASIK procedures, retreatments or lamellar procedures such as lamellar keratoplasty and intracorneal rings segment implantation, and small incision lenticule extraction, as described recently \[[@B9], [@B10], [@B11]\]. In case of simultaneous bilateral surgery, DLK affects both eyes although corneal involvement should be different.

Classification of DLK is extremely important for an early diagnosis and effective treatment. There are various classifications reported for DLK. The most common classifications are those of Machat (1999) \[[@B8]\], Linebarger (2000) \[[@B12]\], and Azar (2001) \[[@B13]\]. Based on the severity of the inflammation, DLK has been classified into four stages \[[@B13]\], from stage I with traces of white granular cells in the periphery of the flap, vision and refraction usually unaffected, to stage IV that is very rare (incidence: 1/5,000 cases), characterized by stromal melting, scarring, and vision loss. At this stage, there is a peak in aggregation of inflammatory cells and release of collagenase by the neutrophils in the interface, which results in corneal melting and tissue loss \[[@B12], [@B13], [@B14]\].

Early diagnosis and appropriate treatment should resolve DLK without sequelae; the final visual outcomes are comparable to those of cases with an uneventful postoperative course, as suggested by Stulting et al. \[[@B14]\]. Once DLK has been diagnosed, the surgeon should follow DLK evolution with accurate biomicroscopy, autorefractometry, refractive examination, corneal topography, anterior segment OCT, and noncontact pachymetry.

The majority of surgeons agree that topical steroid-based therapy (0.2% dexamethasone, 1% prednisolone acetate, 1% rimexolone) and topical antibiotic therapy (fluoroquinolones) are the gold standard for the treatment of less severe and peripheral cases \[[@B15]\]. Once a more advanced stage has been identified (grade 2 Machat, stage 3 Linebarger, type II Azar), the flap can be lifted with careful irrigation of the stromal bed and of the internal face of the flap with balanced saline solution and additional washing with steroids and antibiotics, if necessary. This should be performed as soon as possible, on day 2 or 3, to interrupt the inflammatory response and to prevent corneal melting and permanent scarring \[[@B15]\]. However, lifting the flap can increase the incidence of striae \[[@B13]\], and evidence in the literature showed that treatment of severe DLK with topical and oral high-dose steroids produces excellent results without flap lifting and interface irrigation \[[@B4], [@B13], [@B14], [@B16]\].

It is also known that when the cornea is injured, corneal epithelial cells and other local cells immediately release a large number of mediators, including nitric oxide, interleukin 1, and matrix metalloproteinases (MMPs), to recruit inflammatory cells into the local injured cornea \[[@B4]\], so treating the corneal inflammatory response could prevent corneal melting even in the advanced stage of DLK.

Based on these data, we immediately started intensive topical therapy with dexamethasone eyedrops in addition to prophylactic antibiotic treatment. On day 5, when slit lamp biomicroscopy showed worsening of DLK in both eyes, we started to use oral doxycycline and topical 10% sodium citrate for their anticollagenase activity, as suggested by Jarade et al. \[[@B4]\].

Oral doxycycline is a semisynthetic tetracycline that is well recognized for its therapeutic efficacy in treating MMP-mediated ocular surface diseases such as rosacea, recurrent epithelial erosions, and ocular burns. Doxycycline can promote wound healing by reducing inflammation and protease activity of MMPs, by inhibiting macrophage recruitment, and by decreasing vascular endothelial growth factor C, interleukin 1b, inducible nitric oxide synthase, and tumor necrosis factor-α expression. By chelating divalent actions, sodium citrate might interfere with polymorphonuclear cell diapedesis and complement activation; it has been reported to decrease the production of chemotactic factors and to inhibit the stimulation and release of enzymes from polymorphonuclear cells \[[@B4]\].

In our case, improvements in topographic pattern (Fig. [1](#F1){ref-type="fig"}), corneal thickness, anterior segment OCT (Fig. [3](#F3){ref-type="fig"}), and corneal transparency were evident since the second treatment week and at 3 months (Fig. [2g, h](#F2){ref-type="fig"}), 6 months, and 1 year (Fig. [2i, j](#F2){ref-type="fig"}), respectively. OCT documented a reduction in corneal reflectivity from the periphery to the center and from the deeper stroma towards the surface during follow-up (Fig. [3](#F3){ref-type="fig"}). No corneal scarring or permanent vision loss were detected and, even if visual acuity was the same in both eyes, the patient reported a worse quality of vision in the left eye affected by residual thin microstriae.

In conclusion, DLK represents an infrequent complication after femto-LASIK. It should resolve without sequelae if promptly diagnosed and treated. High-dose topical steroids, hyperosmolar ophthalmological solution, oral doxycycline, and 10% sodium citrate eyedrops could promote corneal healing, without necessity of corneal flap lifting.
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![Corneal topography, tangential map, of the right eye (upper line, from left to right) and of the left eye (bottom line, from left to right) during follow-up. **a** Before surgery. **b** One month after surgery. **c** Three months after surgery. **d** Six months after surgery. **e** One year after surgery.](cop-0009-0457-g01){#F1}

![Digital slit lamp images of the corneal surface of the right eye (left column) and of the left eye (right column) during follow-up. **a**, **b** One day after surgery. **c**, **d** Five days after surgery. **e**, **f** One month after surgery. **g**, **h** Three months after surgery, **i**, **j** One year after surgery.](cop-0009-0457-g02){#F2}

![OCT of the anterior segment of the right eye (left column) and of the left eye (right column) during follow-up. **a**, **b** Five days after surgery. **c**, **d** One month after surgery. **e**, **f** Three months after surgery. **g**, **h** Six months after surgery. **i**, **j** One year after surgery.](cop-0009-0457-g03){#F3}
